Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
DNLI on Nasdaq
E. Krognes - trading volume in the past year for Denali Therapeutics Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
812K |
$23.6M |
$29.03 |
Sep 30, 2024 |
Indirect |
|
|
| Common Stock |
29.1K |
$845K |
$29.03 |
Sep 30, 2024 |
Direct |
|
|
| Stock Option (right to buy) |
17.9K |
|
|
May 31, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.